BCI
BNGO icon

Brinker Capital Investments’s Bionano Genomics BNGO Stock Holding History

Brinker Capital Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27
Closed -$41K – 1355
2022
Q1 		$41K Buy
+27
New +$36.4K ﹤0.01% 1371

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Brinker Capital Investments's BNGO Position: Q2 2022 in Review

Brinker Capital Investments sold out of Bionano Genomics (BNGO) in Q2 2022, closing a stake of 27 shares — an estimated $41K sold.

Brinker Capital Investments first reported a position in BNGO in Q1 2022 and held it in 1 quarter. The position peaked at $41K in Q1 2022. 143 funds tracked by Wall St. Rank hold BNGO as of Q2 2022.

  • Brinker Capital Investments reported no remaining Bionano Genomics position as of Q2 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 27 Bionano Genomics shares in Q2 2022, an estimated $41K.
  • Brinker Capital Investments first reported a position in Bionano Genomics in Q1 2022 and held it in 1 quarter.
  • Brinker Capital Investments's Bionano Genomics position peaked at $41K in Q1 2022.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2022.

Based on Brinker Capital Investments's 13F filing for Q2 2022, filed 18 Jul 2022.